Trials / Completed
CompletedNCT05006378
Effect of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Stony Brook University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Chamomile may possess anticoagulant effects based on the presence of coumarin-like compounds within the flower. This randomized, placebo-controlled complete crossover study will investigate the impact of chamomile ingestion on coagulation.
Detailed description
Subjects will be enrolled into three groups in a crossover fashion upon obtaining written informed consent. Baseline laboratory screening assays of anticoagulation will be obtained. The three intervention groups include (1) chamomile tea intake, (2) chamomile extract intake and (3) placebo capsules. Subjects will consume the chamomile or placebo preparations for one week and partake in a one-week washout period between interventions. Screening assays of coagulation will be obtained immediately before and after each intervention week.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Chamomile Tea | Chamomile tea bags consumed by subjects as described in study arms section. |
| DIETARY_SUPPLEMENT | Chamomile Extract Capsule | Chamomile extract capsules consumed by subjects as described in "Experimental: Chamomile Extract Capsule" study arms section. |
| DIETARY_SUPPLEMENT | Placebo Capsule | Placebo capsules consumed by subjects as described in "Placebo Comparator" study arms section. |
Timeline
- Start date
- 2021-08-31
- Primary completion
- 2022-01-19
- Completion
- 2022-01-19
- First posted
- 2021-08-16
- Last updated
- 2022-02-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05006378. Inclusion in this directory is not an endorsement.